Overview of microarray analysis of gene expression and its applications to cervical cancer investigation

Taiwanese Journal of Obstetrics and Gynecology

Volumn 46, Issue 4, 2007, Pages 363-373

  Chao, Angel ^a   Wang, Tzu Hao ^a,b   Lai, Chyong Huey ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cervix; Gene expression; Microarray; Neoplasm

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; LYMPHOCYTE ANTIGEN; MESOTHELIN; NUCLEIC ACID BINDING PROTEIN; PROTEIN S 100; TUMOR ASSOCIATED CALCIUM SIGNAL TRANSDUCER 1; UNCLASSIFIED DRUG;

ADENOCARCINOMA; CANCER CELL CULTURE; DNA MICROARRAY; FUNCTIONAL GENOMICS; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; IMAGE ANALYSIS; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; PROGNOSIS; RADIATION; REVIEW; TAIWAN; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; WART VIRUS;

EID: 35348843188     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(08)60005-4     Document Type: Article

References (68)

1. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29:365-71.
2. Cancer Registration Annual Report in Taiwan. Department of Health, Executive Yuan, Taiwan, 2002.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
4. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
5. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
6. Chao A, Wang TH, Lee YS, et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 2006;119:91-8.
7. Lai CH, Huang HJ, Hsueh S, et al. Human papillomavirus genotype in cervical cancer: a population-based study. Int J Cancer 2007;120:1999-2006.
8. rd edition. Philadelphia: Lippincott Williams & Wilkins, 2000:345-405.
9. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, Williams CJ. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001;358:781-6.
10. Snyder AR, Morgan WF. Gene expression profiling after irradiation: clues to understanding acute and persistent responses? Cancer Metastasis Rev 2004;23:259-68.
11. Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science 1991;251:767-73.
12. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL. Multiplexed biochemical assays with biological chips. Nature 1993;364:555-6.
13. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
14. Wang TH, Chao A. Microarray analysis of gene expression of cancer to guide the use of chemotherapeutics. Taiwan J Obstet Gynecol 2007;46:222-9.
15. Stekel D. Microarray Bioinformatics. Cambridge: Cambridge University Press, 2003.
16. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM. Expression profiling using cDNA microarrays. Nat Genet 1999;21:10-4.
17. Wang TH, Lee YS, Chen ES, et al. Establishment of cDNA microarray analysis at the Genomic Medicine Research Core Laboratory (GMRCL) of Chang Gung Memorial Hospital. Chang Gung Med J 2004;27:243-60.
18. Yang YH, Speed T. Design issues for cDNA microarray experiments. Nat Rev Genet 2002;3:579-88.
19. rd edition. New Jersey: Prentice Hall, 2002.
20. Chao A, Wang TH, Lee YS, et al. Analysis of functional groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation. Radiat Res (In press).
21. Adams R, Bischof L. Seeded region growing. IEEE Trans Pattern Anal Mach Intell 1994;16:641-47.
22. Kamberova G, Shah S. DNA Array Image Analysis: Nuts and Bolts. Eagleville: DNA Press, 2002.
23. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002;32:496-501.
24. Kooperberg C, Fazzio TG, Delrow JJ, Tsukiyama T. Improved background correction for spotted DNA microarrays. J Comput Biol 2002;9:55-66.
25. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002;18(Suppl 1):S96-104.
26. rd edition. London: Edward Arnold, 1993.
27. Chatfield C, Collins AJ. Introduction to Multivariate Analysis. London: Chapman & Hall, 1980.
28. Dysvik B, Jonassen I. J-Express: exploring gene expression data using Java. Bioinformatics 2001;17:369-70.
29. Raychaudhuri S, Stuart JM, Altman RB. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput 2000:455-66.
30. Xia X, Xie Z. AMADA: analysis of microarray data. Bioinformatics 2001;17:569-70.
31. Kohonen T. Self Organized Maps. Berlin: Springer, 2000.
32. Microarray standards at last. Nature 2002;419:323.
33. Rainen L, Oelmueller U, Jurgensen S, et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002;48:1883-90.
34. Thach DC, Lin B, Walter E, Kruzelock R, Rowley RK, Tibbetts C, Stenger DA. Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. J Immunol Methods 2003;283:269-79.
35. Chai V, Vassilakos A, Lee Y, Wright JA, Young AH. Optimization of the PAXgene blood RNA extraction system for gene expression analysis of clinical samples. J Clin Lab Anal 2005;19:182-8.
36. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003;100:1896-901.
37. Lee YS, Chen CH, Chao A, et al. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005;6:132.
38. Tsuang MT, Nossova N, Yager T, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005;133:1-5.
39. Hamaoui K, Butt A, Powrie J, Swaminathan R. Concentration of circulating rhodopsin mRNA in diabetic retinopathy. Clin Chem 2004;50:2152-5.
40. Li D, Butt A, Clarke S, Swaminathana R. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects. Ann N Y Acad Sci 2004;1022:147-51.
41. Muller MC, Merx K, Weisser A, Kreil S, Lahaye T, Hehlmann R, Hochhaus A. Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization. Leukemia 2002;16:2395-9.
42. -ΔΔT method. Methods 2001;25:402-8.
43. Fujimoto T, Nishikawa A, Iwasaki M, Akutagawa N, Teramoto M, Kudo R. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array. Gynecol Oncol 2004;93:446-53.
44. Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 2002;4:295-303.
45. Wong YF, Selvanayagam ZE, Wei N, et al. Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. Clin Cancer Res 2003;9:5486-92.
46. Harima Y, Togashi A, Horikoshi K, et al. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 2004; 60:237-48.
47. Chung YM, Kim BG, Park CS, et al. Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 2005;117:194-201.
48. Wong YF, Sahota DS, Cheung TH, et al. Gene expression pattern associated with radiotherapy sensitivity in cervical cancer. Cancer J 2006;12:189-93.
49. Achary MP, Jaggernauth W, Gross E, Alfieri A, Klinger HP, Vikram B. Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression. Cytogenet Cell Genet 2000;91:39-43.
50. Chaudhry MA, Chodosh LA, McKenna WG, Muschel RJ. Gene expression profile of human cells irradiated in G1 and G2 phases of cell cycle. Cancer Lett 2003;195:221-33.
51. Chen X, Shen B, Xia L, Khaletzkiy A, Chu D, Wong JY, Li JJ. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes. Cancer Res 2002;62: 1213-21.
52. Chopra V, Dinh TV, Hannigan EV. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 1998;16:152-9.
53. Comerci JT Jr, Runowicz CD, Flanders KC, De Victoria C, Fields AL, Kadish AS, Goldberg GL. Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer 1996;77:1107-14.
54. Kloth JN, Fleuren GJ, Oosting J, et al. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines. Carcinogenesis 2005;26:1493-502.
55. Hudelist G, Czerwenka K, Singer C, Pischinger K, Kubista E, Manavi M. cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study. Cancer Genet Cytogenet 2005;158:35-42.
56. Cheng Q, Lau WM, Tay SK, Chew SH, Ho TH, Hui KM. Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma. Int J Cancer 2002;98:419-26.
57. Shim C, Zhang W, Rhee CH, Lee JH. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 1998; 4:3045-50.
58. Chen Y, Miller C, Mosher R, et al. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res 2003;63:1927-35.
59. Pappa KI, Anagnou NP. Emerging issues of the expression profiling technologies for the study of gynecologic cancer. Am J Obstet Gynecol 2005;193:908-18.
60. Kendrick JE, Conner MG, Huh WK. Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia. J Low Genit Tract Dis 2007;11:25-8.
61. Contag SA, Gostout BS, Clayton AC, Dixon MH, McGovern RM, Calhoun ES. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 2004;95:610-7.
62. Wong YF, Cheung TH, Tsao GS, et al. Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 2006; 118:2461-9.
63. Harima Y, Sawada S, Miyazaki Y, et al. Expression of Ku80 in cervical cancer correlates with response to radiotherapy and survival. Am J Clin Oncol 2003;26:e80-5.
64. Thomas G. The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncol 2001; 28:60-5.
65. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
66. Tewari D, Monk BJ, Al-Ghazi MS, Parker R, Heck JD, Burger RA, Fruehauf JP. Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study. Gynecol Oncol 2005;99:84-91.
67. Kruse JJ, te Poele JA, Russell NS, Boersma LJ, Stewart FA. Microarray analysis to identify molecular mechanisms of radiation-induced microvascular damage in normal tissues. Int J Radiat Oncol Biol Phys 2004;58:420-6.
68. Narayan G, Bourdon V, Chaganti S, et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 2007;46: 373-84.